Nigrostriatal reconstruction after 6-OHDA lesions in rats: combination of dopamine-rich nigral grafts and nigrostriatal "bridge" grafts
- PMID: 2568267
- DOI: 10.1007/BF00249903
Nigrostriatal reconstruction after 6-OHDA lesions in rats: combination of dopamine-rich nigral grafts and nigrostriatal "bridge" grafts
Abstract
In an attempt to reconstruct the nigrostriatal dopamine (DA) pathway following 6-hydroxydopamine-induced degeneration in adult rats, a novel double graft procedure has been developed. Embryonic DA-rich grafts were implanted in the vicinity of the host substantia nigra by standard procedures. An intracerebral bridge was then implanted by injection of alternative tissues along a single oblique needle penetration through the frontal pole and neostriatum to the substantia nigra. Embryonic striatal tissue bridges provided a continuous column of tissue from the nigral DA graft to the host striatum. In 3 cases, tyrosine hydroxylase immunoreactive fibres grew the full length of the striatal bridge grafts and were seen to penetrate the host neostriatum. In these three animals alone, methylamphetamine-induced rotation was significantly reduced to 44% of the baseline lesion-induced turning rate. Alternative tissues or substrates (embryonic olfactory bulb, cultured astrocytes or laminin-coated microspheres) were not effective in promoting THir fibre growth from the nigral DA grafts to the host neostriatum.
Similar articles
-
Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants.J Neurosci. 1996 Nov 15;16(22):7216-27. doi: 10.1523/JNEUROSCI.16-22-07216.1996. J Neurosci. 1996. PMID: 8929430 Free PMC article.
-
Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues.Exp Brain Res. 1988;71(2):411-24. doi: 10.1007/BF00247501. Exp Brain Res. 1988. PMID: 2901978
-
Nigral grafts in neonatal rats protect from aphagia induced by subsequent adult 6-OHDA lesions: the importance of striatal location.Exp Brain Res. 1990;80(1):172-6. doi: 10.1007/BF00228858. Exp Brain Res. 1990. PMID: 2113481
-
Nigral grafts in neonatal rats: protection from aphagia induced by subsequent adult 6-OHDA lesions.Prog Brain Res. 1990;82:489-92. doi: 10.1016/s0079-6123(08)62638-2. Prog Brain Res. 1990. PMID: 2127115 Review. No abstract available.
-
6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.Pharmacol Ther B. 1976;2(1):37-40. doi: 10.1016/0306-039x(76)90016-7. Pharmacol Ther B. 1976. PMID: 772721 Review. No abstract available.
Cited by
-
Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.J Neurosci. 2000 Jul 1;20(13):5102-14. doi: 10.1523/JNEUROSCI.20-13-05102.2000. J Neurosci. 2000. PMID: 10864967 Free PMC article.
-
Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.NPJ Parkinsons Dis. 2020 Jan 8;6:4. doi: 10.1038/s41531-019-0105-5. eCollection 2020. NPJ Parkinsons Dis. 2020. PMID: 31934611 Free PMC article. Review.
-
Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants.J Neurosci. 1996 Nov 15;16(22):7216-27. doi: 10.1523/JNEUROSCI.16-22-07216.1996. J Neurosci. 1996. PMID: 8929430 Free PMC article.
-
Historical perspective of cell transplantation in Parkinson's disease.World J Transplant. 2017 Jun 24;7(3):179-192. doi: 10.5500/wjt.v7.i3.179. World J Transplant. 2017. PMID: 28698835 Free PMC article. Review.
-
Injectable Glycosaminoglycan-Based Cryogels from Well-Defined Microscale Templates for Local Growth Factor Delivery.ACS Chem Neurosci. 2021 Apr 7;12(7):1178-1188. doi: 10.1021/acschemneuro.1c00005. Epub 2021 Mar 23. ACS Chem Neurosci. 2021. PMID: 33754692 Free PMC article.